Catalyst Wire Dossier Catalyst Wire Dossier

voxilaprevir

voxilaprevir · Gilead Sciences
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for voxilaprevir, covering 2017-09-15 to 2023-09-27. Get the full timeline:

Most recent: EMA Authorised: Vosevi (sofosbuvir;velpatasvir;voxilaprevi) — Gilead Sciences Ireland UC

See pricing